Japan’s Astellas agrees to acquire Belgian firm Ogeda for EUR800m

This article was originally published here

Japan-based Astellas Pharma has agreed to acquire Belgium’s clinical-stage drug discovery firm Ogeda for around €800m.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply